These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27196002)

  • 41. Polyethylenimines for siRNA and miRNA delivery in vivo.
    Höbel S; Aigner A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noncoding RNA for Cancer Gene Therapy.
    Zhong X; Zhang D; Xiong M; Zhang L
    Recent Results Cancer Res; 2016; 209():51-60. PubMed ID: 28101687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attacking the genome: emerging siRNA nanocarriers from concept to clinic.
    Alabi C; Vegas A; Anderson D
    Curr Opin Pharmacol; 2012 Aug; 12(4):427-33. PubMed ID: 22726555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From structures to functions: insights into exosomes as promising drug delivery vehicles.
    Ren J; He W; Zheng L; Duan H
    Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigation of Content, Stoichiometry and Transfer of miRNA from Human Neural Stem Cell Line Derived Exosomes.
    Stevanato L; Thanabalasundaram L; Vysokov N; Sinden JD
    PLoS One; 2016; 11(1):e0146353. PubMed ID: 26752061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current progress on microRNAs-based therapeutics in neurodegenerative diseases.
    Pereira P; Queiroz JA; Figueiras A; Sousa F
    Wiley Interdiscip Rev RNA; 2017 May; 8(3):. PubMed ID: 27882692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis.
    Gorshkov A; Purvinsh L; Brodskaia A; Vasin A
    Nanomaterials (Basel); 2022 Feb; 12(3):. PubMed ID: 35159869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
    O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.
    Yang Z; Xie J; Zhu J; Kang C; Chiang C; Wang X; Wang X; Kuang T; Chen F; Chen Z; Zhang A; Yu B; Lee RJ; Teng L; Lee LJ
    J Control Release; 2016 Dec; 243():160-171. PubMed ID: 27742443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping.
    Zheng Z; Li Z; Xu C; Guo B; Guo P
    J Control Release; 2019 Oct; 311-312():43-49. PubMed ID: 31446085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delivery of Functional Small RNAs via Extracellular Vesicles In Vitro and In Vivo.
    Zhang D; Lee H; Jin Y
    Methods Mol Biol; 2020; 2115():107-117. PubMed ID: 32006397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
    Lee SH; Chung BH; Park TG; Nam YS; Mok H
    Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exosome-Modified Tissue Engineered Blood Vessel for Endothelial Progenitor Cell Capture and Targeted siRNA Delivery.
    Chen W; Yang M; Bai J; Li X; Kong X; Gao Y; Bi L; Xiao L; Shi B
    Macromol Biosci; 2018 Feb; 18(2):. PubMed ID: 29205878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
    Aigner A; Fischer D
    Pharmazie; 2016 Jan; 71(1):27-34. PubMed ID: 26867350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
    Huang X; Guo H; Wang L; Zhang Z; Zhang W
    Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosome mediated communication within the tumor microenvironment.
    Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
    J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photocontrolled Intracellular RNA Delivery Using Nanoparticles or Carrier-Photosensitizer Conjugates.
    Watanabe K; Ohtsuki T
    Prog Mol Biol Transl Sci; 2016; 139():101-19. PubMed ID: 26970192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.